Corporate News     28-Dec-21
Board of Ajanta Pharma approves buy-back of shares
On 28 December 2021
The Board of Ajanta Pharma on 28 December 2021 has approved the Buy-back of up to 11,20,000 fully paid-up Equity Shares of face value of Rs.2/- each by the Company (representing 1.29%of the total number of Equity Shares of the Company) at a price of Rs.2, 550/- per Equity Share payable in cash for a total consideration not exceeding Rs.285.60 crores.
Previous News
  Ajanta Pharma consolidated net profit rises 65.82% in the March 2024 quarter
 ( Results - Announcements 02-May-24   16:53 )
  Ajanta Pharma consolidated net profit rises 24.71% in the September 2023 quarter
 ( Results - Announcements 31-Oct-23   14:10 )
  Ajanta Pharma
 ( Results - Analysis 01-Feb-23   17:14 )
  Volumes jump at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 03-May-24   11:00 )
  Ajanta Pharma fixes record date for buyback of shares
 ( Market Beat - Reports 03-Nov-20   16:40 )
  Ajanta Pharma slides after Q4 PAT drops 19% YoY to Rs 122 cr
 ( Hot Pursuit - 08-May-23   11:45 )
  Sensex tanks 909 pts; European mkt opens higher
 ( Market Commentary - Mid-Session 03-May-24   13:42 )
  Ajanta Pharma consolidated net profit rises 18.09% in the June 2024 quarter
 ( Results - Announcements 30-Jul-24   16:46 )
  Ajanta Pharma
 ( Results - Analysis 03-Nov-21   17:38 )
  Board of Ajanta Pharma to consider buyback of shares
 ( Corporate News - 23-Dec-21   16:42 )
  Ajanta Pharma's Dahej unit undergoes USFDA audit
 ( Corporate News - 12-Sep-22   12:00 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top